Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent Against Mycobacterium tuberculosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent Against Mycobacterium tuberculosis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-11-17
DOI
10.3389/fphar.2021.746496
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydrogel-Forming Algae Polysaccharides: From Seaweed to Biomedical Applications
- (2021) Marco Beaumont et al. BIOMACROMOLECULES
- Seaweed Polysaccharide Based Products and Materials: An Assessment on Their Production from a Sustainability Point of View
- (2021) Nishith A. Chudasama et al. MOLECULES
- Latent Tuberculosis Infection Treatment Completion while Shifting Prescription from Isoniazid-Only to Rifampicin-Containing Regimens: A Two-Decade Experience in Milan, Italy
- (2020) Simone Villa et al. Journal of Clinical Medicine
- The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system
- (2020) Sarah M. Batt et al. BIOCHEMICAL JOURNAL
- Health Impact of Silver Nanoparticles: A Review of the Biodistribution and Toxicity Following Various Routes of Exposure
- (2020) Zannatul Ferdous et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Silver Nanoparticles for the Therapy of Tuberculosis
- (2020) Alexandru-Flaviu Tăbăran et al. International Journal of Nanomedicine
- The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry
- (2020) Iris Xiaoxue Yin et al. International Journal of Nanomedicine
- New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
- (2020) Gauri S. Shetye et al. Translational Research
- Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs
- (2020) Catherine Vilchèze Applied Sciences-Basel
- The Immune Escape Mechanisms of Mycobacterium Tuberculosis
- (2019) Weijie Zhai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bactericidal and Cytotoxic Properties of Silver Nanoparticles
- (2019) Chengzhu Liao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rifampicin conjugated silver nanoparticles: a new arena for development of antibiofilm potential against methicillin resistant Staphylococcus aureus and Klebsiella pneumoniae
- (2019) Umar Farooq et al. International Journal of Nanomedicine
- Immune Response to Mycobacterium tuberculosis: A Narrative Review
- (2019) Maurizio de Martino et al. Frontiers in Pediatrics
- Fungicidal and anti-biofilm activities of trimethylchitosan-stabilized silver nanoparticles against Candida species in zebrafish embryos
- (2019) Shao-Hung Wang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Antibiotic‐Free Antibacterial Strategies Enabled by Nanomaterials: Progress and Perspectives
- (2019) Yue Wang et al. ADVANCED MATERIALS
- Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia
- (2018) Leonar Arroyo et al. BMC INFECTIOUS DISEASES
- Chondroitin sulfate-stabilized silver nanoparticles: Improved synthesis and their catalytic, antimicrobial, and biocompatible activities
- (2018) Jenn-jong Young et al. CARBOHYDRATE RESEARCH
- Green synthesis of sodium alginate-silver nanoparticles and their antibacterial activity
- (2018) Ying Shao et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies
- (2018) Yun'an Qing et al. International Journal of Nanomedicine
- Viability, biofilm formation, and MazEF expression in drug-sensitive and drug-resistant Mycobacterium tuberculosis strains circulating in Xinjiang, China
- (2018) Jili Zhao et al. Infection and Drug Resistance
- Small Heat Shock Protein16.3 of Mycobacterium tuberculosis: After Two Decades of Functional Characterization
- (2018) Babban Jee et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Plasma membrane is the target of rapid antibacterial action of silver nanoparticles in Escherichia coli and Pseudomonas aeruginosa
- (2018) Olesja M Bondarenko et al. International Journal of Nanomedicine
- Bedaquiline: Fallible Hope Against Drug Resistant Tuberculosis
- (2017) Priya Singh et al. INDIAN JOURNAL OF MICROBIOLOGY
- The antimicrobial activity of nanoparticles: present situation and prospects for the future
- (2017) Linlin Wang et al. International Journal of Nanomedicine
- Mechanistic Study of the Synergistic Antibacterial Activity of Combined Silver Nanoparticles and Common Antibiotics
- (2016) Hua Deng et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
- (2016) Xi-Feng Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Characterization of Alginate/Silver Nanobiocomposites Synthesized by Solution Plasma Process and Their Antimicrobial Properties
- (2016) Sangwoo Nam et al. Journal of Nanomaterials
- Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles
- (2016) Tikam Chand Dakal et al. Frontiers in Microbiology
- Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis
- (2016) Hlumani Ndlovu et al. Frontiers in Immunology
- Alternative Antimicrobial Approach: Nano-Antimicrobial Materials
- (2015) Nurit Beyth et al. Evidence-based Complementary and Alternative Medicine
- The future for early-stage tuberculosis drug discovery
- (2015) Edison S Zuniga et al. Future Microbiology
- Nanoparticle uptake: The phagocyte problem
- (2015) Heather Herd Gustafson et al. Nano Today
- Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
- (2015) Guido V. Bloemberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets
- (2015) K. Mdluli et al. Cold Spring Harbor Perspectives in Medicine
- Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
- (2015) Kwonjune J. Seung et al. Cold Spring Harbor Perspectives in Medicine
- Green synthesis of chondroitin sulfate-capped silver nanoparticles: Characterization and surface modification
- (2014) Kuang-ming Cheng et al. CARBOHYDRATE POLYMERS
- Beyond macrophages: the diversity of mononuclear cells in tuberculosis
- (2014) Smita Srivastava et al. IMMUNOLOGICAL REVIEWS
- Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms
- (2014) N. K. Dutta et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Macrophages in tuberculosis: friend or foe
- (2013) Evelyn Guirado et al. Seminars in Immunopathology
- Use of Silver in the Prevention and Treatment of Infections: Silver Review
- (2013) Amani D. Politano et al. Surgical Infections
- Fabrication of antibacterial silver nanoparticle—sodium alginate–chitosan composite films
- (2012) Shilpa Sharma et al. RSC Advances
- Micelles/sodium-alginate composite gel beads: A new matrix for oral drug delivery of indomethacin
- (2011) Xiujuan Huang et al. CARBOHYDRATE POLYMERS
- Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide
- (2011) L.D. Ghiraldi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Latent tuberculosis: what the host “sees”?
- (2011) Hannah P. Gideon et al. IMMUNOLOGIC RESEARCH
- Potential role for ESAT6 in dissemination ofM.âtuberculosisvia human lung epithelial cells
- (2009) Arvind G. Kinhikar et al. MOLECULAR MICROBIOLOGY
- Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties
- (2009) Melissa M Kemp et al. NANOTECHNOLOGY
- Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells
- (2008) P. V. AshaRani et al. ACS Nano
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started